Heptagon Driehaus US MicroCapEqSEEURAcc |
Performance History | 30/04/2024 |
Growth of 1,000 (EUR) |
Fund | - | - | -28.8 | 8.6 | 10.7 | |
+/-Cat | - | - | -11.4 | -4.5 | 7.5 | |
+/-Idx | - | - | -14.5 | -6.2 | 9.5 | |
Category: US Small-Cap Equity | ||||||
Benchmarks: Morningstar US Small Extend... |
Key Stats | ||
NAV 09/05/2024 | EUR 104.36 | |
Day Change | 0.61% | |
Morningstar Category™ | US Small-Cap Equity | |
ISIN | IE00BDB54R98 | |
Fund Size (Mil) 08/05/2024 | USD 827.37 | |
Share Class Size (Mil) 08/05/2024 | EUR 24.36 | |
Max Initial Charge | 3.00% | |
Ongoing Charge 01/01/2024 | 1.20% |
Investment Objective: Heptagon Driehaus US MicroCapEqSEEURAcc |
The investment objective of the Fund is to achieve long-term capital growth. The Fund uses a growth style of investment in equity securities, whereby the Sub-Investment Manager seeks out investments with good growth potential. Under normal market conditions, the Fund will invest at least 80% of its net assets in the equity securities, including common and preferred stocks, of U.S. micro-capitalization (“micro-cap”) companies. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Jeffrey James 07/12/2016 | ||
Michael Buck 07/12/2016 | ||
Click here to see others | ||
Inception Date 25/01/2021 |
Advertisement |
Benchmarks | |
Fund Benchmark | Morningstar Benchmark |
Russell Micro Cap Growth TR USD | Morningstar US Small Extended NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Heptagon Driehaus US MicroCapEqSEEURAcc | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Crinetics Pharmaceuticals Inc | Healthcare | 2.96 |
Modine Manufacturing Co | Consumer Cyclical | 2.66 |
Camtek Ltd | Technology | 2.24 |
FTAI Aviation Ltd | Industrials | 2.22 |
Xenon Pharmaceuticals Inc | Healthcare | 1.91 |
Increase Decrease New since last portfolio | ||
Heptagon Driehaus US MicroCapEqSEEURAcc |